BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24779963)

  • 1. DNA methylation in obesity and type 2 diabetes.
    de Mello VD; Pulkkinen L; Lalli M; Kolehmainen M; Pihlajamäki J; Uusitupa M
    Ann Med; 2014 May; 46(3):103-13. PubMed ID: 24779963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human.
    Simar D; Versteyhe S; Donkin I; Liu J; Hesson L; Nylander V; Fossum A; Barrès R
    Metabolism; 2014 Sep; 63(9):1188-97. PubMed ID: 24996265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic flexibility in metabolic regulation: disease cause and prevention?
    Kirchner H; Osler ME; Krook A; Zierath JR
    Trends Cell Biol; 2013 May; 23(5):203-9. PubMed ID: 23277089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives.
    Milagro FI; Mansego ML; De Miguel C; Martínez JA
    Mol Aspects Med; 2013; 34(4):782-812. PubMed ID: 22771541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.
    Nilsson E; Matte A; Perfilyev A; de Mello VD; Käkelä P; Pihlajamäki J; Ling C
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1491-501. PubMed ID: 26418287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes.
    Nilsson E; Jansson PA; Perfilyev A; Volkov P; Pedersen M; Svensson MK; Poulsen P; Ribel-Madsen R; Pedersen NL; Almgren P; Fadista J; Rönn T; Klarlund Pedersen B; Scheele C; Vaag A; Ling C
    Diabetes; 2014 Sep; 63(9):2962-76. PubMed ID: 24812430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility.
    Portha B; Fournier A; Kioon MD; Mezger V; Movassat J
    Biochimie; 2014 Feb; 97():1-15. PubMed ID: 24139903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on the IASO Stock Conference 2006: early and lifelong environmental epigenomic programming of metabolic syndrome, obesity and type II diabetes.
    Junien C; Nathanielsz P
    Obes Rev; 2007 Nov; 8(6):487-502. PubMed ID: 17949354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics in Human Obesity and Type 2 Diabetes.
    Ling C; Rönn T
    Cell Metab; 2019 May; 29(5):1028-1044. PubMed ID: 30982733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational diabetes mellitus, programing and epigenetics.
    Yan J; Yang H
    J Matern Fetal Neonatal Med; 2014 Aug; 27(12):1266-9. PubMed ID: 24125565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental origins of type 2 diabetes: Focus on epigenetics.
    Vaiserman A; Lushchak O
    Ageing Res Rev; 2019 Nov; 55():100957. PubMed ID: 31473332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and DNA methylation regulation in the metabolic syndrome.
    Yara S; Lavoie JC; Levy E
    Epigenomics; 2015; 7(2):283-300. PubMed ID: 25942536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional Factors, DNA Methylation, and Risk of Type 2 Diabetes and Obesity: Perspectives and Challenges.
    Parrillo L; Spinelli R; Nicolò A; Longo M; Mirra P; Raciti GA; Miele C; Beguinot F
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic changes in early life and future risk of obesity.
    Lillycrop KA; Burdge GC
    Int J Obes (Lond); 2011 Jan; 35(1):72-83. PubMed ID: 20548303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation links genetics, fetal environment, and an unhealthy lifestyle to the development of type 2 diabetes.
    Nilsson E; Ling C
    Clin Epigenetics; 2017; 9():105. PubMed ID: 29026446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics and maternal nutrition: nature v. nurture.
    Simmons R
    Proc Nutr Soc; 2011 Feb; 70(1):73-81. PubMed ID: 21110912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology.
    Csoka AB; Szyf M
    Med Hypotheses; 2009 Nov; 73(5):770-80. PubMed ID: 19501473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental origins of beta-cell failure in type 2 diabetes: the role of epigenetic mechanisms.
    Simmons RA
    Pediatr Res; 2007 May; 61(5 Pt 2):64R-67R. PubMed ID: 17413845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mini-review: Mitochondrial DNA methylation in type 2 diabetes and obesity.
    Rautenberg EK; Hamzaoui Y; Coletta DK
    Front Endocrinol (Lausanne); 2022; 13():968268. PubMed ID: 36093112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of type 2 diabetes related modules and genes based on epigenetic networks.
    Liu H; Wang T; Liu H; Wei Y; Zhao G; Su J; Wu Q; Qiao H; Zhang Y
    BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S5. PubMed ID: 24565181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.